Psychedelics Small-scale Nature study shows psilocybin causes brain changes after one use Compass Pathways provided the synthetic compound used in the research process Rowan DunneMay 7, 2026
Psychedelics XTL Biopharma to enter psychedelics sector with Psyga Bio takeover The move was significantly inspired by Trump's recent executive order Rowan DunneMay 4, 2026
Psychedelics Compass Pathways scores FDA priority voucher for synthetic psilocybin drug Three companies were awarded the vouchers after Trump's executive order was signed Rowan DunneApril 30, 2026
Psychedelics Optimi Health launches ibogaine initiative in response to Trump’s executive order Psychedelic stocks surged after the president gave his signature Rowan DunneApril 21, 2026
Psychedelics Trump prepares to sign executive order for expedited ibogaine research Sources just informed CBS News about the significant development Rowan DunneApril 17, 2026
Cannabis Bioxyne to manufacture Aurora Cannabis products for international distribution The company went from a one-person operation to partnering with one of the world's cannabis majors Rowan DunneApril 6, 2026
Psychedelics Israeli scientists get tobacco to produce array of psychedelic compounds The novel method has significant implications for clinical psychedelic drug production Rowan DunneApril 2, 2026
Psychedelics Deutsche Bank initiates bullish coverage of psychedelics company AtaiBeckley The financial institution has given the drug developer a Buy rating a US$12 share target Rowan DunneMarch 31, 2026
Psychedelics Psilocybin truffle maker Red Light Holland to acquire financially distressed Filament Health Both companies have balance sheets with concerning numbers Rowan DunneMarch 11, 2026
Psychedelics Psychedelic retreat organiser charged with manslaughter over 2021 incident He provided a guest with ayahuasca and administered frog venom (kambo) in Australia Rowan DunneMarch 5, 2026